vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and OLD SECOND BANCORP INC (OSBC). Click either name above to swap in a different company.

Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $93.8M, roughly 1.1× OLD SECOND BANCORP INC). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 15.1%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

IMCR vs OSBC — Head-to-Head

Bigger by revenue
IMCR
IMCR
1.1× larger
IMCR
$104.5M
$93.8M
OSBC
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
15.1%
OSBC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IMCR
IMCR
OSBC
OSBC
Revenue
$104.5M
$93.8M
Net Profit
$25.6M
Gross Margin
97.4%
Operating Margin
-18.8%
Net Margin
27.3%
Revenue YoY
24.3%
Net Profit YoY
159.2%
EPS (diluted)
$-0.61
$0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
OSBC
OSBC
Q1 26
$93.8M
Q4 25
$104.5M
$95.2M
Q3 25
$103.7M
$95.9M
Q2 25
$98.0M
$75.1M
Q1 25
$93.9M
$73.1M
Q4 24
$84.1M
$73.2M
Q3 24
$80.2M
$71.2M
Q2 24
$75.4M
$70.8M
Net Profit
IMCR
IMCR
OSBC
OSBC
Q1 26
$25.6M
Q4 25
Q3 25
$-177.0K
$9.9M
Q2 25
$-10.3M
$21.8M
Q1 25
$5.0M
$19.8M
Q4 24
Q3 24
$8.7M
$23.0M
Q2 24
$-11.6M
$21.9M
Gross Margin
IMCR
IMCR
OSBC
OSBC
Q1 26
Q4 25
97.4%
Q3 25
99.5%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Operating Margin
IMCR
IMCR
OSBC
OSBC
Q1 26
Q4 25
-18.8%
41.2%
Q3 25
-6.9%
13.6%
Q2 25
-15.2%
38.9%
Q1 25
-3.9%
35.8%
Q4 24
-23.1%
34.7%
Q3 24
-10.6%
41.9%
Q2 24
-21.2%
41.2%
Net Margin
IMCR
IMCR
OSBC
OSBC
Q1 26
27.3%
Q4 25
Q3 25
-0.2%
10.3%
Q2 25
-10.5%
29.0%
Q1 25
5.4%
27.1%
Q4 24
Q3 24
10.9%
32.3%
Q2 24
-15.4%
30.9%
EPS (diluted)
IMCR
IMCR
OSBC
OSBC
Q1 26
$0.48
Q4 25
$-0.61
$0.53
Q3 25
$0.00
$0.18
Q2 25
$-0.20
$0.48
Q1 25
$0.10
$0.43
Q4 24
$-0.47
$0.42
Q3 24
$0.17
$0.50
Q2 24
$-0.23
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
OSBC
OSBC
Cash + ST InvestmentsLiquidity on hand
$864.2M
$115.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$381.0M
$893.3M
Total Assets
$1.1B
$6.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
OSBC
OSBC
Q1 26
$115.7M
Q4 25
$864.2M
$124.0M
Q3 25
$892.4M
$116.5M
Q2 25
$882.8M
$141.8M
Q1 25
$837.0M
$256.1M
Q4 24
$820.4M
$99.3M
Q3 24
$901.3M
$115.8M
Q2 24
$859.6M
$120.9M
Total Debt
IMCR
IMCR
OSBC
OSBC
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$438.7M
Q2 24
$452.5M
Stockholders' Equity
IMCR
IMCR
OSBC
OSBC
Q1 26
$893.3M
Q4 25
$381.0M
$896.8M
Q3 25
$396.6M
$866.7M
Q2 25
$388.5M
$718.6M
Q1 25
$378.5M
$694.5M
Q4 24
$360.7M
$671.0M
Q3 24
$377.8M
$661.4M
Q2 24
$359.1M
$619.3M
Total Assets
IMCR
IMCR
OSBC
OSBC
Q1 26
$6.8B
Q4 25
$1.1B
$6.9B
Q3 25
$1.1B
$7.0B
Q2 25
$1.1B
$5.7B
Q1 25
$1.0B
$5.7B
Q4 24
$1.0B
$5.6B
Q3 24
$1.1B
$5.7B
Q2 24
$1.0B
$5.7B
Debt / Equity
IMCR
IMCR
OSBC
OSBC
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.16×
Q2 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
OSBC
OSBC
Operating Cash FlowLast quarter
$-32.7M
Free Cash FlowOCF − Capex
$-35.5M
FCF MarginFCF / Revenue
-34.0%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-15.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
OSBC
OSBC
Q1 26
Q4 25
$-32.7M
$122.3M
Q3 25
$-4.5M
$35.9M
Q2 25
$26.0M
$24.2M
Q1 25
$435.0K
$17.8M
Q4 24
$-14.0M
$131.5M
Q3 24
$21.1M
$48.5M
Q2 24
$23.5M
$11.6M
Free Cash Flow
IMCR
IMCR
OSBC
OSBC
Q1 26
Q4 25
$-35.5M
$117.8M
Q3 25
$-5.2M
$34.7M
Q2 25
$25.6M
$23.5M
Q1 25
$137.0K
$16.2M
Q4 24
$-17.5M
$120.7M
Q3 24
$20.3M
$46.2M
Q2 24
$23.1M
$8.7M
FCF Margin
IMCR
IMCR
OSBC
OSBC
Q1 26
Q4 25
-34.0%
123.7%
Q3 25
-5.0%
36.2%
Q2 25
26.1%
31.2%
Q1 25
0.1%
22.2%
Q4 24
-20.9%
165.0%
Q3 24
25.3%
64.9%
Q2 24
30.7%
12.3%
Capex Intensity
IMCR
IMCR
OSBC
OSBC
Q1 26
Q4 25
2.8%
4.7%
Q3 25
0.7%
1.3%
Q2 25
0.4%
1.1%
Q1 25
0.3%
2.2%
Q4 24
4.3%
14.7%
Q3 24
1.0%
3.3%
Q2 24
0.4%
4.2%
Cash Conversion
IMCR
IMCR
OSBC
OSBC
Q1 26
Q4 25
Q3 25
3.64×
Q2 25
1.11×
Q1 25
0.09×
0.90×
Q4 24
Q3 24
2.42×
2.11×
Q2 24
0.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCR
IMCR

Segment breakdown not available.

OSBC
OSBC

Net Interest Income$81.1M87%
Noninterest Income$12.6M13%

Related Comparisons